Gateway to Medical Device Development, Commercialization, and Global Expansion

Gateway to Medical Device Development, Commercialization, and Global Expansion

[Tokyo Metropolitan Medical-Engineering Collaboration HUB Organization] Medical-Engineering Collaboration Seminar | Fundamentals of the Pharmaceuticals and Medical Devices Act

This is an event announcement from the Tokyo Metropolitan Medical-Engineering Collaboration HUB Organization.

The Pharmaceuticals and Medical Devices Act (hereinafter referred to as the "Pharmaceuticals and Medical Devices Act") ensures the safety, effectiveness, and quality of medical devices.
This law aims to protect the health of the public, and at the same time, it is a fundamental rule for conducting the medical device business. In medical device development, this includes manufacturing and sales approval, clinical trials, quality control,
The tasks related to the Pharmaceuticals and Medical Devices Act are numerous, including obtaining licenses for the manufacture and sale of medical devices and complying with amendments to the law.
This seminar will feature a member of the Diagnostic and Therapeutic Devices Committee of the American Medical Devices and IVD Manufacturers Association.
We are pleased to welcome Mr. Masanori Otake, Vice Chairman of the RAQA Committee and Vice Chairman of the Digital Health Committee, to speak about the basics and latest trends of the Pharmaceuticals and Medical Devices Act, including regulations concerning medical devices themselves, obligations imposed on companies that handle them, and rules before and after market release.

Knowledge of the Pharmaceuticals and Medical Devices Act is an essential skill in medical device development.
We encourage companies involved in medical device development, as well as those considering entering the medical device industry, to participate.

◆ Medical-Engineering Collaboration Seminar Date and Time: Wednesday, July 10, 2024, 16:00-18:00
Details:https://ikou-hub.tokyo/contents/event/20240710/

"Fundamentals of the Pharmaceuticals and Medical Devices Act"
Masanori Otake, Chairman of the Diagnostic and Therapeutic Devices Committee, RAQA Committee, and Vice Chairman of the Digital Health Committee, The American Association of Medical Devices and IVD Manufacturers.

Commentator: Kazuo Tanishita, Chairman, Japan Medical Engineering Manufacturing Commons Facilitator: Satoshi Kashiwano, Project Manager, Tokyo Medical Engineering Collaboration HUB Organization

Tokyo Metropolitan Medical-Engineering Collaboration HUB Organization